(VIANEWS) – StoneCo (STNE), Stellus Capital Investment Corporation (SCM), iRadimed Corporation (IRMD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. StoneCo (STNE)
16% sales growth and 7.6% return on equity
StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. It distributes its solutions, principally through proprietary Stone Hubs, which offer hyper-local sales and services; and sells solutions to brick-and-mortar and digital merchants through sales team. The company served approximately 2.6 million clients primarily small-and-medium-sized businesses; and marketplaces, e-commerce platforms, and integrated software vendors. StoneCo Ltd. was founded in 2000 and is headquartered in George Town, the Cayman Islands.
Earnings Per Share
As for profitability, StoneCo has a trailing twelve months EPS of $0.65.
PE Ratio
StoneCo has a trailing twelve months price to earnings ratio of 27.14. Meaning, the purchaser of the share is investing $27.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.6%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
StoneCo’s EBITDA is 0.42.
Volume
Today’s last reported volume for StoneCo is 1669810 which is 70.43% below its average volume of 5648290.
Moving Average
StoneCo’s value is way above its 50-day moving average of $13.27 and way above its 200-day moving average of $12.25.
Revenue Growth
Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 11.17B for the twelve trailing months.
2. Stellus Capital Investment Corporation (SCM)
14.1% sales growth and 3.37% return on equity
Stellus Capital Investment Corporation is a business development company specializing in investments in private middle-market companies. It invests through first lien, second lien, unitranche, and mezzanine debt financing, often with a corresponding equity investment. The fund prefers to invest in US and Canada. The fund seeks to invest in companies with an EBITDA between $5 million and $50 million.
Earnings Per Share
As for profitability, Stellus Capital Investment Corporation has a trailing twelve months EPS of $0.48.
PE Ratio
Stellus Capital Investment Corporation has a trailing twelve months price to earnings ratio of 26.5. Meaning, the purchaser of the share is investing $26.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.37%.
Moving Average
Stellus Capital Investment Corporation’s worth is under its 50-day moving average of $12.87 and under its 200-day moving average of $13.85.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 8% and a negative 2.2%, respectively.
3. iRadimed Corporation (IRMD)
13.8% sales growth and 22.62% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Earnings Per Share
As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.3.
PE Ratio
iRadimed Corporation has a trailing twelve months price to earnings ratio of 35.95. Meaning, the purchaser of the share is investing $35.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.62%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 62.97M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 20, 2023, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 0.32%.
Volume
Today’s last reported volume for iRadimed Corporation is 24632 which is 25.82% below its average volume of 33208.
Sales Growth
iRadimed Corporation’s sales growth is 15.2% for the present quarter and 13.8% for the next.
4. Euronet Worldwide (EEFT)
9.4% sales growth and 25.61% return on equity
Euronet Worldwide, Inc. provides payment and transaction processing and distribution solutions to financial institutions, agents, retailers, merchants, content providers, and individual consumers worldwide. The company's Electronic Fund Transfer Processing segment provides electronic payment solutions, including automated teller machine (ATM) cash withdrawal and deposit services, ATM network participation, outsourced ATM and point-of-sale (POS) management solutions, credit and debit card outsourcing, card issuing, and merchant acquiring services. It also offers ATM and POS currency conversion, ATM surcharge, advertising, customer relationship management, mobile top-up, bill payment, fraud management, foreign remittance and cardless payout, banknote recycling, and tax-refund services; and integrated electronic financial transaction software solutions, as well as delivers non-cash products. This segment operates a network of 42,713 ATMs and approximately 438,000 POS terminals. Its epay segment distributes and processed prepaid mobile airtime and other electronic payment products; and provides payment processing services for various prepaid products, cards, and services, as well as vouchers and physical gift fulfillment, and gift card distribution and processing services. This segment operates a network of approximately 775,000 POS terminals. The company's Money Transfer segment offers consumer-to-consumer and account-to-account money transfer, customers bill payment, check cashing, foreign currency exchange, mobile top-up, and cash management and foreign currency risk management services, as well as payment alternatives, such as money orders and prepaid debit cards. This segment operates a network of approximately 510,000 money transfer locations. The company was formerly known as Euronet Services, Inc. and changed its name to Euronet Worldwide, Inc. in August 2001. Euronet Worldwide, Inc. was founded in 1994 and is headquartered in Leawood, Kansas.
Earnings Per Share
As for profitability, Euronet Worldwide has a trailing twelve months EPS of $5.38.
PE Ratio
Euronet Worldwide has a trailing twelve months price to earnings ratio of 18.95. Meaning, the purchaser of the share is investing $18.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.61%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.8%, now sitting on 3.6B for the twelve trailing months.
5. AMETEK (AME)
8.5% sales growth and 16.51% return on equity
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Earnings Per Share
As for profitability, AMETEK has a trailing twelve months EPS of $5.52.
PE Ratio
AMETEK has a trailing twelve months price to earnings ratio of 29.47. Meaning, the purchaser of the share is investing $29.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.51%.
Sales Growth
AMETEK’s sales growth is 6% for the ongoing quarter and 8.5% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.6%, now sitting on 6.49B for the twelve trailing months.
Volume
Today’s last reported volume for AMETEK is 220104 which is 77.32% below its average volume of 970514.
6. RadNet (RDNT)
7.3% sales growth and 4.67% return on equity
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, RadNet has a trailing twelve months EPS of $0.06.
PE Ratio
RadNet has a trailing twelve months price to earnings ratio of 595. Meaning, the purchaser of the share is investing $595 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.67%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RadNet’s EBITDA is 2.3.
Moving Average
RadNet’s worth is way above its 50-day moving average of $31.94 and way higher than its 200-day moving average of $30.07.
